MedTrace Logo

Using Virtual Reality Before Transcranial Magnetic Stimulation for the Treatment of OCD

NCT06442527 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2025-03-07

No results posted yet for this study

Summary

This study will focus on the use of Virtual Reality (VR) technology in patients receiving treatment using Transcranial Magnetic Stimulation (TMS) for Obsessive-Compulsive Disorder (OCD)

Conditions

  • Obsessive-Compulsive Disorder

Interventions

DEVICE

Virtual Reality

Virtual reality gear and content will be used prior to TMS session as part of the provocation items

Sponsors & Collaborators

  • Yale University

    lead OTHER

Principal Investigators

  • Sina Nikayin, MD · Assistant Professor, Departement of Psychiatry, Yale University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-31
Primary Completion
2025-12-31
Completion
2025-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06442527 on ClinicalTrials.gov